Compare FTV & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTV | DXCM |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | 18000 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 26.5B |
| IPO Year | 2015 | 2005 |
| Metric | FTV | DXCM |
|---|---|---|
| Price | $60.76 | $63.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 21 |
| Target Price | $59.18 | ★ $85.33 |
| AVG Volume (30 Days) | 2.3M | ★ 3.5M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | 1.73 | ★ 2.09 |
| Revenue | ★ $6,452,700,000.00 | N/A |
| Revenue This Year | $4.85 | $14.46 |
| Revenue Next Year | $3.74 | $12.31 |
| P/E Ratio | $35.26 | ★ $29.96 |
| Revenue Growth | ★ 12.10 | N/A |
| 52 Week Low | $46.34 | $54.11 |
| 52 Week High | $73.77 | $89.07 |
| Indicator | FTV | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 64.08 | 45.28 |
| Support Level | $53.20 | $60.57 |
| Resistance Level | $62.42 | $69.18 |
| Average True Range (ATR) | 1.45 | 2.04 |
| MACD | 0.34 | 0.21 |
| Stochastic Oscillator | 85.22 | 45.49 |
Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.